A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
Clinical trial NCT07341672 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07341672
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-31
- Primary completion
- 2027-04-23
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.